Results of Search
BCRJ: | 0240 | Cell Line: | U266B1 [U266] | Tissue: | | Organ: | PERIPHERAL BLOOD | Cell Type: | B LYMPHOCYTE | Morphology: | LYMPHOBLAST | Pathology: | MYELOMA | Scientific Name: | HOMO SAPIENS | Vulgar Name: | HUMAN | Sex: | MALE | Miscelaneous Info: | | Virus Succeptibility: | | Virus Resistance: | | Tumor Formation: | | Products: | immunoglobulin; monoclonal antibody; interleukin 6 (interleukin-6, IL-6) | Dependency Isoenzymes: | | Culture Medium: | The base medium for this cell line is RPMI-1640 Medium. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 15%.
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 3 x 10 exp5 cells/ml and maintain between 1 x 10 exp5 and 1 x 10 exp6 cells/ml. | Consigner: | PRISCILA SEGGES
INCA | Reference: | 1180: Nilsson K, et al. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin. Exp. Immunol. 7: 477-489, 1970. PubMed: 4097745
22377: Kawano M, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988. PubMed: 3258060
32396: Kolanus W, et al. alphaLbeta2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1 a cytoplasmic regulatory molecule. Cell 86: 233-242, 1996. PubMed: 8706128 | Additional Info: | U266 cells have been reported to produce human IL-6.
DNA Profile (STR): Amelogenin: X,Y
CSF1PO: 12,13
D13S317: 12
D16S539: 10
D5S818: 11,12
D7S820: 11,12
THO1: 5,7
TPOX: 8
vWA: 17 | ATCC: | TIB-196 | Biosafety: | 01 |
|